No Data
Guangzheng Ophthalmology: Report for the third quarter of 2024
Guangzheng Eye Hospital Group (002524.SZ) released its performance for the first three quarters, with a net loss of 20.8086 million yuan.
Guangzheng Eye Hospital Group (002524.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
guangzheng eye hospital group (002524.SZ): a net loss of 20.8086 million yuan in the first three quarters.
Guangzheng Eye Hospital Group (002524.SZ) announced its third quarter report for 2024 on October 24. In the first three quarters of 2024, the company achieved revenue of 0.699 billion yuan, a decrease of 15.49% year-on-year; net income attributable to shareholders of the listed company suffered a loss of 20.8086 million yuan, a decrease of 299.40% year-on-year; net income, excluding non-recurring gains and losses, suffered a loss of 29.4314 million yuan, a decrease of 1150.98% year-on-year; basic earnings per share incurred a loss of 0.04 yuan per share.
Express News | Guangzheng Eye Hospital Group: The controlling shareholder plans to increase the registered capital and change the equity structure.
A-share ophthalmology concept stocks rise, guangzheng eye hospital group hits the limit up.
September 9th, Guangzheng Eye Hospital Group hit the daily price limit, Heshi Eye Hospital Group made a push for the daily limit, Puleye Eye Hospital Group, Huaxia Eye Hospital Group, Aier Eye Hospital Group and others followed the rise.
Guangzheng Ophthalmology: Semi-Annual Report 2024
No Data
No Data